Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandra Ramirez-Venegas

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Clinical Characteristics of Patients With Biomass Smoke-Associated COPD and Chronic Bronchitis, 2004-2014Rogelio Pérez-Padilla, Alejandra Ramirez-Venegas, Raul Sansores-Martinez
The European Respiratory Journal|July 2, 2014
From the authorsAlejandra Ramirez-Venegas, Raul H Sansores, Pat G Camp, et al.
Frontiers in Bioscience (Scholar Edition)|January 2, 2013
Urban PM2.5 activates GAPDH and induces RBC damage in COPD patientsAraceli Montoya-Estrada, Yessica D Torres-Ramos, Arturo Flores-Pliego, et al.
Archivos De Bronconeumologia|January 11, 2018
Demographic Characteristics and Clinical Outcomes in Patients from Latin America Versus the Rest of the World: A TIOSPIR<sup>®</sup> Post-Hoc AnalysisAntonio Anzueto, Peter M A Calverley, Achim Mueller, et al.
Frontiers in Bioscience (Elite Edition)|June 3, 2010
RBC membrane damage and decreased band 3 phospho-tyrosine phosphatase activity are markers of COPD progressionYessica Dorin Torres-Ramos, Alberto Martin Guzman-Grenfell, Araceli Montoya-Estrada, et al.
Plos One|November 16, 2017
Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC studyMaria Montes de Oca, Ana Menezes, Fernando C Wehrmeister, et al.
Respiratory Medicine|February 8, 2018
Prevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: The LASSYC observational studyMarc Miravitlles, Ana Menezes, Maria Victorina López Varela, et al.
Frontiers in Bioscience (Elite Edition)|May 31, 2011
Urban PM2.5 induces ROS generation and RBC damage in COPD patientsYessica D Torres-Ramos, Araceli Montoya-Estrada, Alberto M Guzman-Grenfell, et al.
Pulmonary Therapy|March 6, 2024
Association between Increased Risk of Pneumonia with ICS in COPD: A Continuous Variable Analysis of Patient Factors from the IMPACT StudyBhumika Aggarwal, Paul Jones, Alejandro Casas, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 14, 2009
Geographic differences in clinical characteristics and management of COPD: the EPOCA studyMarc Miravitlles, Cristina Murio, Gema Tirado-Conde, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
Clinical Characteristics of Patients With Biomass Smoke-Associated COPD and Chronic Bronchitis, 2004-2014Rogelio Pérez-Padilla, Alejandra Ramirez-Venegas, Raul Sansores-Martinez
The European Respiratory Journal|July 2, 2014
From the authorsAlejandra Ramirez-Venegas, Raul H Sansores, Pat G Camp, et al.
Frontiers in Bioscience (Scholar Edition)|January 2, 2013
Urban PM2.5 activates GAPDH and induces RBC damage in COPD patientsAraceli Montoya-Estrada, Yessica D Torres-Ramos, Arturo Flores-Pliego, et al.
Archivos De Bronconeumologia|January 11, 2018
Demographic Characteristics and Clinical Outcomes in Patients from Latin America Versus the Rest of the World: A TIOSPIR<sup>®</sup> Post-Hoc AnalysisAntonio Anzueto, Peter M A Calverley, Achim Mueller, et al.
Frontiers in Bioscience (Elite Edition)|June 3, 2010
RBC membrane damage and decreased band 3 phospho-tyrosine phosphatase activity are markers of COPD progressionYessica Dorin Torres-Ramos, Alberto Martin Guzman-Grenfell, Araceli Montoya-Estrada, et al.
Plos One|November 16, 2017
Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC studyMaria Montes de Oca, Ana Menezes, Fernando C Wehrmeister, et al.
Respiratory Medicine|February 8, 2018
Prevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: The LASSYC observational studyMarc Miravitlles, Ana Menezes, Maria Victorina López Varela, et al.
Frontiers in Bioscience (Elite Edition)|May 31, 2011
Urban PM2.5 induces ROS generation and RBC damage in COPD patientsYessica D Torres-Ramos, Araceli Montoya-Estrada, Alberto M Guzman-Grenfell, et al.
Pulmonary Therapy|March 6, 2024
Association between Increased Risk of Pneumonia with ICS in COPD: A Continuous Variable Analysis of Patient Factors from the IMPACT StudyBhumika Aggarwal, Paul Jones, Alejandro Casas, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 14, 2009
Geographic differences in clinical characteristics and management of COPD: the EPOCA studyMarc Miravitlles, Cristina Murio, Gema Tirado-Conde, et al.
Pageof 2